Abstract Body

Background

Pregnant women living with HIV (PWLHIV) are at elevated risk of adverse maternal and infant outcomes especially when coinfected with sexually transmitted infections (STIs). HIV clinical indicators such as ART use, viral load, and timing of diagnosis are proxies for care engagement and health-seeking behaviours, which may be associated with STI prevalence. We examined the distribution of curable STIs by HIV clinical factors among PWLHIV in South Africa.

Methods

We analysed baseline data from PWLHIV in the Philani Ndiphile trial (2021–2024). At first ANC visit, women were screened for HIV and syphilis using rapid test followed by laboratory confirmation. Vaginal swabs were tested via GeneXpert point-of-care tests for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). Recent viral load (VL) results were obtained from the National Health Laboratory Service or drawn if absent. ART status and recent HIV diagnosis (≤1 week before first ANC) were self-reported. We estimated prevalence with 95% CIs for any STI and individual organisms. Associations between HIV clinical factors and any STI were assessed with logistic regression adjusted for maternal and gestational age.

Results

Among 488 PWLHIV [median age 30 years, IQR 26–34; gestational age 13 weeks, IQR 8–18], 83% were on ART, 83.7% had an undetectable VL (<50 copies/mL), and 15.4% had a recent HIV diagnosis. Overall, 32.8% (95% CI 28.5–37.4) had ≥1 curable STI: CT 14.5%, TV 17.0%, NG 5.1%, and syphilis 4.5%. Prevalence of any STI was similar among those on and not on ART (32% vs 37%, p = 0.49), and whether HIV diagnosis was recent (≤1 week) or longer standing (>1 week) (38% vs 34%, p = 0.73). STI prevalence was 46% among women with low-level viremia (50–999 copies/mL), 40% with high-level viremia (≥1000 copies/mL), and 32% with undetectable VL. Compared with undetectable VL, no significant associations were observed for low-level (aOR 1.86, 95% CI 0.95–3.62) or high-level viremia (aOR 1.37, 95% CI 0.72–2.55).

Conclusions

We observed a high prevalence of curable STIs among PWLHIV in South Africa, irrespective of treatment status, diagnosis timing, or viral load. These findings support the need for universal, integrated STI and HIV screening and treatment in antenatal care to reduce preventable adverse outcomes in high-burden settings.